The DOI matches its Crossref record.
Serum Total Homocysteine and Coronary Heart Disease
Abstract
BACKGROUND: Several studies have observed high plasma levels of homocysteine among patients with coronary heart disease (CHD). The only prospective study was based on US physicians, and concluded that homocysteine was associated with subsequent myocardial infarction (MI). However, the association was limited to those above a threshold level of homocysteine. METHODS: We conducted a nested case-control study among the 21,826 subjects, aged 12-61 years, who were surveyed in the municipality of Tromsø, Norway. Among those free from MI at the screening, 123 later developed CHD. Four controls were selected for each case. RESULTS: Level of homocysteine was higher in cases than in controls (12.7 +/- 4.7 versus 11.3 +/- 3.7 mumol/l (mean +/- SD); P = 0.002). The relative risk for a 4 mumol/l increase in serum homocysteine was 1.41 (95% confidence interval (CI): 1.16-1.71). Adjusting for possible confounders reduced the relative risk to 1.32 (95% CI: 1.05-1.65). There was no threshold level above which serum homocysteine is associated with CHD events. CONCLUSIONS: In the general population serum total homocysteine is an independent risk factor for CHD with no threshold level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Self-citationHomocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Self-citationPlasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Self-citationThe Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W. F., & Rosenberg, I. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401901 · Cited by 1,117
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Total Plasma Homocysteine and Cardiovascular Risk Profile: The Hordaland Homocysteine Study
Nygård, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., Ueland, P. M., & Kvåle, G. (1995) · JAMA · doi:10.1001/jama.1995.03530190040032 · Cited by 1,042
Self-citationHomocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Self-citationFihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
Rimm, E. B. (1998) · JAMA · doi:10.1001/jama.279.5.359 · Cited by 815
Cohort profile: The Tromso Study
Jacobsen, B. K., Eggen, A. E., Mathiesen, E. B., Wilsgaard, T., & Njolstad, I. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr049 · Cited by 694
Brattström, L., Wilcken, D. E. L., Öhrvik, J., & Brudin, L. (1998) · Circulation · doi:10.1161/01.cir.98.23.2520 · Cited by 659
Folsom, A. R., Nieto, F. J., McGovern, P. G., Tsai, M. Y., Malinow, M. R., Eckfeldt, J. H., Hess, D. L., & Davis, C. E. (1998) · Circulation · doi:10.1161/01.cir.98.3.204 · Cited by 603
Malinow, M. R., Bostom, A. G., & Krauss, R. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.178 · Cited by 586
Robinson, K., Arheart, K., Refsum, H., Brattström, L., Boers, G., Ueland, P., Rubba, P., Palma-Reis, R., Meleady, R., Daly, L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.5.437 · Cited by 550
Self-citationHomocysteine and coronary atherosclerosis
Mayer, E. L., Jacobsen, D. W., & Robinson, K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00508-0 · Cited by 519
The controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Self-citationVerhoef, P., Stampfer, M. J., Buring, J. F., Gaziano, J. M., Allen, R. H., Stabler, S. P., Reynolds, R. D., Kok, F. J., Hennekens, C. H., & Willett, W. C. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008828 · Cited by 480
Ma, J., Stampfer, M. J., Hennekens, C. H., Frosst, P., Selhub, J., Horsford, J., Malinow, M. R., Willett, W. C., & Rozen, R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2410 · Cited by 479
Bostom, A. G., & Lathrop, L. (1997) · Kidney International · doi:10.1038/ki.1997.298 · Cited by 456
Homocysteine and Thrombotic Disease
D'Angelo, A., & Selhub, J. (1997) · Blood · doi:10.1182/blood.v90.1.1 · Cited by 439
Homocysteine and vitamins in cardiovascular disease
Jacobsen, D. W. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1833 · Cited by 418
Moustapha, A., Naso, A., Nahlawi, M., Gupta, A., Arheart, K. L., Jacobsen, D. W., Robinson, K., & Dennis, V. W. (1998) · Circulation · doi:10.1161/01.cir.97.2.138 · Cited by 405
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.277.22.1775 · Cited by 405
Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis
Humphrey, L. L., Fu, R., Rogers, K., Freeman, M., & Helfand, M. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.11.1203 · Cited by 396
Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 382
Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., & Scott, J. M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.862 · Cited by 369
Hyperhomocysteinemia, Atherosclerosis and Thrombosis
Cattaneo, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614438 · Cited by 362
Homocysteine-Induced Endothelial Dysfunction
Lai, W. K. C., & Kan, M. Y. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000437098 · Cited by 357
New Risk Factors for Atherosclerosis and Patient Risk Assessment
Fruchart, J.-C., Nierman, M. C., Stroes, E. S. G., Kastelein, J. J. P., & Duriez, P. (2004) · Circulation · doi:10.1161/01.cir.0000131513.33892.5b · Cited by 348
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
The Hordaland Homocysteine Studies
Ueland, P. M., Nygård, O., Vollset, S. E., & Refsum, H. (2001) · Lipids · doi:10.1007/s11745-001-0679-7 · Cited by 328
Self-citationWollesen, F., Brattström, L., Refsum, H., Ueland, P. M., Berglund, L., & Berne, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.0550031028.x · Cited by 325
Self-citationEvaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323
Folic acid and folates: the feasibility for nutritional enhancement in plant foods
Scott, J., R�beill�, F., & Fletcher, J. (2000) · Journal of the Science of Food and Agriculture · doi:10.1002/(sici)1097-0010(20000515)80:7<795::aid-jsfa599>3.0.co;2-k · Cited by 322
Tonstad, S., Joakimsen, O., Stensland-Bugge, E., Leren, T. P., Ose, L., Russell, D., & Bønaa, K. H. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.984 · Cited by 314
Self-citationBlood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304
Homocysteine and cardiovascular disease: a review of the evidence
Wierzbicki, A. S. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.033 · Cited by 287
De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 282
Homocysteine and Hyperhomocysteinaemia
Zaric, B. L., Obradovic, M., Bajic, V., Haidara, M. A., Jovanovic, M., & Isenovic, E. R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180313105949 · Cited by 281
Gaughan, D. J., Kluijtmans, L. A. J., Barbaux, S., McMaster, D., Young, I. S., Yarnell, J. W. G., Evans, A., & Whitehead, A. S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00739-5 · Cited by 277
Do age-related macular degeneration and cardiovascular disease share common antecedents?
Snow, K. K., & Seddon, J. M. (1999) · Ophthalmic Epidemiology · doi:10.1076/opep.6.2.125.1558 · Cited by 274
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2000) · Circulation · doi:10.1161/01.cir.101.13.1506 · Cited by 273
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S., & Blache, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780275 · Cited by 261
Bots, M. L., Launer, L. J., Lindemans, J., Hoes, A. W., Hofman, A., Witteman, J. C. M., Koudstaal, P. J., & Grobbee, D. E. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.38 · Cited by 260
Total homocysteine and cardiovascular disease
Nygård, O., Vollset, S. E., Refsum, H., Brattström, L., & Ueland, P. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00512.x · Cited by 256
Self-citationHarmon, D. L., Shields, D. C., Woodside, J. V., McMaster, D., Yarnell, J. W. G., Young, I. S., Peng, K., Shane, B., Evans, A. E., & Whitehead, A. S. (1999) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(199911)17:4<298::aid-gepi5>3.0.co;2-v · Cited by 256
Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women
Ridker, P. M. (1999) · JAMA · doi:10.1001/jama.281.19.1817 · Cited by 253
Ioannidis, J. P. A. (2011) · JAMA · doi:10.1001/jama.2011.713 · Cited by 252
The nested case-control study in cardiology
Essebag, V., Genest, J., Suissa, S., & Pilote, L. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00512-x · Cited by 173
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
“A number of mechanisms have been advanced to explain the inverse associations between tHcy and levels of cognitive performance: 1) higher levels of tHcy are neurotoxic (12, 13); 2) elevation in tHcy is seen in the presence of deficits in the tHcy vitamin cofactors, that is, folate, vitamin B6, and vitamin B12 (14, 15)…”
BackgroundProspective Studies of Homocysteine and Cardiovascular Disease
Verhoef, P., & Stampfer, M. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1995.tb01478.x · Cited by 58
Goran, M. I., Shaibi, G. Q., Weigensberg, M. J., Davis, J. N., & Cruz, M. L. (2006) · International Journal of Pediatric Obesity · doi:10.1080/17477160600780423 · Cited by 50
Redéen, S., Ryberg, A., Petersson, F., Eriksson, O., Nägga, K., & Borch, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0761-0 · Cited by 26
Metadata
- Authors
- ARNESEN, E., REFSUM, H., BØNAA, K. H., UELAND, P. M., FØRDE, O. H., & NORDREHAUG, J. E.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995
- Volume
- 24
- Issue
- 4
- Pages
- 704-709
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2058737278
- Cited by
- 651
- References
- 0
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.